Wall Street, Features, BI Prime, Healthcare, pharma, Strategy, Dispensed, Health,

$11 billion drugmaker Mylan and US drug giant Pfizer are teaming up to reshape Mylan’s business. 3 tough questions from Wall Street analyst show the challenging road ahead.

By

Spencer Platt/Getty The drugmaker Mylan is combining with a Pfizer unit that makes off-patent drugs like Viagra. The all-stock deal was announced on Monday and aims to revitalize Mylan’s flagging stock.  Three tough questions from Wall Street analysts on a Monday conference call show why the spinoff could face an uphill battle.  Analysts questioned the […]

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.